Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide plus Megestrol Acetate in Obese Women with Endometrial Atypical Hyperplasia
NCT04683237Phase 3Withdrawn
- Start
- Mar 2021
- Primary completion
- Nov 2025
- Modality
- Peptides
01
Overview
A Phase 3 trial of liraglutide in Atypical endometrial hyperplasia (AEH). Planned start Mar 2021; status: withdrawn.
02
Drugs
03
Conditions
Atypical endometrial hyperplasia (AEH)
Beyond the preview
Go deeper on NCT04683237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04683237.